NuOncology Labs, Inc. Stock Other OTC
Equities
NLAB
US67057T1079
Business Support Services
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 156M |
---|---|---|---|---|---|
Net income 2021 | - | Net income 2022 | - | EV / Sales 2021 * | - |
Net cash position 2021 * | - | Net Debt 2022 | 41.88K | EV / Sales 2022 | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-2,229
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Yan-Ping Sheng
CEO | Chief Executive Officer | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yan-Ping Sheng
CEO | Chief Executive Officer | 63 | - |
Sunny Sukardi
CHM | Chairman | 59 | 23-01-30 |
1st Jan change | Capi. | |
---|---|---|
+10.55% | 67.5B | |
+11.64% | 18.12B | |
+9.40% | 13.4B | |
+16.53% | 9.97B | |
-32.90% | 5.7B | |
-10.98% | 5.53B | |
-4.09% | 4.92B | |
-4.83% | 4.86B | |
0.00% | 4.33B |